Post-socialist Models of Rule in Central and Southeastern Europe

Author(s):  
Sabrina P. Ramet ◽  
F. Peter Wagner
2012 ◽  
Vol 37 (1) ◽  
pp. 105-125 ◽  
Author(s):  
Siegfried Gruber ◽  
Mikołaj Szołtysek

This article makes a new contribution to the discussion of historical European family forms. Its starting points are two recent contributions by Steven Ruggles in which the author discussed the historical appearances of stem and joint families across the globe. Drawing on most recent developments in census microdata infrastructure from historical Eastern, Central, and Southeastern Europe, the authors pinpoint limitations pertaining to the usage of IPUMS (Integrated Public Use Microdata Series) and NAPP (North Atlantic Population Project) collections for the investigation of European family systems. Using newly acquired materials and refined conceptual tools, they enhance the knowledge about the spatiotemporal distribution of stem- and joint-family arrangements in a broader European context. As the frequency of joint families in the regions under study cannot be fully accounted for by referring to measures of economic conditions and demographic structures alone, the authors speculate about some additional factors which may explain the observed differences in joint-family coresidence across historic Eastern Europe.


2019 ◽  
Vol 28 (2) ◽  
pp. 137-142 ◽  
Author(s):  
Katherine Lebow ◽  
Małgorzata Mazurek ◽  
Joanna Wawrzyniak

The events of 1914 initiated the redrawing of many boundaries, both geopolitical and intellectual. At the outbreak of the war the London-based anthropologist Bronisław Malinowski was at a professional meeting in Australia. Technically an ‘enemy alien’ (a Pole of Austro-Hungarian citizenship), he was barred from returning to Britain; stranded in Australia, under surveillance by authorities and with insecure finances, Malinowski began fieldwork in the Trobriand Islands that would result in his groundbreakingArgonauts of the Western Pacific(1922).1Argonauts’ influence rested on its compelling portrait of the anthropologist as ‘participant-observer’, the insider/outsider uniquely poised to decode and recode cultures and meanings.2Malinowski thus adeptly retooled his own ambiguous status into a paradigm of the ethnographer’s optimal subject-position – quipping that he himself was particularly suited to this role, as ‘the Slavonic nature is more plastic and more naturally savage than that of Western Europeans’.3


2009 ◽  
Vol 27 (15_suppl) ◽  
pp. 6546-6546
Author(s):  
T. Brodowicz ◽  
I. Steiner ◽  
S. Beslija ◽  
T. E. Ciuleanu ◽  
M. Inbar ◽  
...  

6546 Background: CECOG has been formed in 1999 to unite centers of clinical oncology from Central and Southeastern Europe and Israel in order to conduct and coordinate multicenter oncology RCTs. Based on the European legislation passed in 2001 (Directive 2001/20/EC), clinical trials must get ethical approval and approval from the competent authorities (CA). However, the duration of these regulatory procedures to initiate a clinical trial is a factor determining the competitive position in clinical research. Methods: Within the last 10 years, CECOG conducted trials in breast, colorectal, esophago-gastric, NSCLC, pancreatic, prostate cancer and GIST. We analyzed the dates of FPA, the approvals by Ethics Review Boards (ERB) and CAs, the letters of agreement between sponsor and site (LoA), the site initiation and the inclusion of the first patient in a total of 6 multicenter trials in 25 CECOG study centers in Austria, Bosnia, Bulgaria, Croatia, the Czech Republic, Hungary, Israel, Poland, Romania, Serbia, and Slovakia. Results: The average time interval from FPA to the inclusion of the first patient was 18.4 ± 9.4 months. Most of this time has been spent for regulatory procedures, i.e. the approval by ERBs (9.6 ± 7.2 months) and CAs (10.0 ± 6.6 months). The LoA were signed 11.5 ± 9.4 months after FPA. The time interval from approval by the CAs to site initiation was 3.3 ± 3.7 months and the interval between site initiation and the inclusion of the first patient was 4.2 ± 4.5 months. Conclusions: The ‘paper to patient process‘ - the time interval between the approval of the final study protocol and the inclusion of the first patient - required 18.4 months on average in 6 multicenter trials conducted by CECOG. As the regulatory procedures used up more than 50% of duration of the whole process, optimization is necessary and realistic in order to make novel therapies available to patients more quickly. No significant financial relationships to disclose.


2014 ◽  
Vol 124 (1) ◽  
pp. 199-220 ◽  
Author(s):  
Ermira Kamberi ◽  
Borja Martinovic ◽  
Maykel Verkuyten

Sign in / Sign up

Export Citation Format

Share Document